Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential
- PMID: 14511033
- DOI: 10.1046/j.1464-410x.2003.04415.x
Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential
Abstract
Objective: To evaluate the long-term outcome of bladder papillary urothelial neoplasms of low malignant potential (PUNLMP).
Patients and methods: Of 475 consecutive patients with newly diagnosed bladder tumours between 1976 and 1993, 330 (69%) had superficial (Ta and T1) tumours and 53 (11%) were diagnosed as having PUNLMP. Fifty patients (mean age at presentation 57.2 years, range 26-83; male-to-female ratio 6 : 1) who were followed for> 5 years or until they died, were included in the present study. All histological slides were reviewed, and fulfilled the diagnostic criteria of the 1998 World Health Organization/International Society of Urological Pathology classification system.
Results: The mean (median, range) follow-up was 11.7 (10.8, 1.3-24.4) years. During the follow-up, 30 patients (60%) had local recurrences. The 2, 5 and 10-year recurrence-free rates were 66%, 51% and 36%, respectively. No patients developed high-grade or muscle-invasive (>/= T2) carcinomas, or upper urinary tract tumours, or died from the disease. At the last follow-up, 34 patients (68%) had been disease-free for> 5 years.
Conclusions: Despite a high recurrence rate, PUNLMP carries a very low malignant potential. We agree with the use of the term 'papillary urothelial neoplasms of low malignant potential' instead of 'superficial bladder carcinoma (cancer)' for these tumours.
Similar articles
-
Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth.Diagn Pathol. 2015 Mar 13;10:3. doi: 10.1186/s13000-015-0234-z. Diagn Pathol. 2015. PMID: 25886613 Free PMC article.
-
Reappraisal of the papillary urothelial neoplasm of low malignant potential (PUNLMP).Histopathology. 2020 Oct;77(4):525-535. doi: 10.1111/his.14192. Epub 2020 Sep 13. Histopathology. 2020. PMID: 32562556 Review.
-
A population-based study of 538 patients with newly detected urinary bladder neoplasms followed during 5 years.Scand J Urol Nephrol. 2003;37(3):195-201. doi: 10.1080/00365590310008037. Scand J Urol Nephrol. 2003. PMID: 12775276
-
The Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers.Urol J. 2019 Dec 24;16(6):558-562. doi: 10.22037/uj.v0i0.4519. Urol J. 2019. PMID: 30882164
-
[New WHO classification of urothelial carcinoma of the urinary bladder].Verh Dtsch Ges Pathol. 2002;86:57-66. Verh Dtsch Ges Pathol. 2002. PMID: 12647352 Review. German.
Cited by
-
Urothelial carcinoma of the urinary bladder in pediatric patients: a long-term follow-up.Int Urol Nephrol. 2015 May;47(5):771-4. doi: 10.1007/s11255-015-0950-z. Epub 2015 Mar 19. Int Urol Nephrol. 2015. PMID: 25787072
-
Reproducibility and reliability of tumor grading in urological neoplasms.World J Urol. 2007 Dec;25(6):595-605. doi: 10.1007/s00345-007-0209-0. Epub 2007 Sep 9. World J Urol. 2007. PMID: 17828603 Review.
-
Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.Virchows Arch. 2011 Jun;458(6):659-64. doi: 10.1007/s00428-011-1072-3. Epub 2011 Apr 12. Virchows Arch. 2011. PMID: 21484429
-
Reproductibilité des classifications OMS 1973 et OMS 2004 des tumeurs urothéliales papillaires de la vessie.Can Urol Assoc J. 2012 Dec;6(6):E230-3. doi: 10.5489/cuaj.10078. Epub 2011 Sep 8. Can Urol Assoc J. 2012. PMID: 21914428 Free PMC article. English.
-
Reproducibility and prognostic value of WHO1973 and WHO2004 grading systems in TaT1 urothelial carcinoma of the urinary bladder.PLoS One. 2014 Jan 7;9(1):e83192. doi: 10.1371/journal.pone.0083192. eCollection 2014. PLoS One. 2014. PMID: 24409280 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical